Published December 18, 2024 | Version v1

RNAseq data of SUM159 and SW620 ALDHbr and ALDHneg cells treated with Nifuroxazide Vs control condition (DMSO)

  • 1. Institut Paoli-Calmettes
  • 2. Cancer Research Center of Marseille

Description

In order to understand the biological processes occurring in breast (SUM159) and colon (SW620) cancer stem cells (ALDHpos) and non-cancer stem cells (ALDHneg) when exposed to Nifuroxazide compare to control condition, we performed a comparative transcriptomic study on:

 

NIF_ALDpos (breast CSC exposed 30h to Nifuroxazide),

NIF_ALDneg (non-breast CSC exposed 30h to Nifuroxazide)

CTRLpos (breast CSC exposed 30h to DMSO)

CTRLneg (non-breast CSC exposed to DMSO)

AldhposNIF (colon CSC exposed 30h to Nifuroxazide),

AldhnegNIF (non-colon CSC exposed 30h to Nifuroxazide)

Aldhpos (colon CSC exposed 30h to DMSO)

Aldhneg (noncolon CSC exposed to DMSO)

 

We preformed bulk RNA-sequencing on triplicates for each condition.

The text file contains raw counts data of our RNA-seq analysis.

Files

merged_Analysis_Raw_Counts.txt

Files (2.5 MB)

Name Size
md5:650f36bd1b9acdbafff08f935d122b56
2.5 MB Preview Download

Additional details

Related works

Is supplement to
Preprint: 10.21203/rs.3.rs-4763425/v1 (DOI)